12:00 AM
Apr 27, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Apomab: Phase Ib started

Roche began an open-label Phase Ib trial to evaluate IV Apomab in combination with FOLFOX chemotherapy and Avastin bevacizumab in 23 patients. Avastin is...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >